Abstract
Personalized medicine offers a custom-made treatment for each patient directed by information of individuals genetic variation. Despite plenty of information about human single nucleotide polymorphisms (SNPs) and gene expression profile, predicting functions of genetic variations in humans is still a difficult task. Genetic analysis using experimental animals is possible to provide information about the functions of genetic polymorphisms over experimental invention in humans. In particular, inbred strains established from wild mice are valuable resources for analyzing functions of genetic polymorphisms. In this article, first I describe history of inbred strains derived from Japanese wild mice, Mus musuclus molossinus. Next, I discuss a mouse model for hyperlipidemia, which was isolated from a colony of Japanese wild mice. Interestingly, the hyperlipimic phenotypes are varied in congenic strains on other genetic backgrounds, reflecting phenotype variation of hyperlipidemia in human populations. Thus, further genetic analysis of Japanese wild mice can contribute to functional analysis of human genetic variation leading to personalized medicine.
Keywords: Polymorphisms, Wild Mice, nucleotide, Mus musuclus molossinus, genetic variation
Current Pharmaceutical Biotechnology
Title: The New Disease Models from Genetic Polymorphisms of Japanese Wild Mice
Volume: 10 Issue: 2
Author(s): Yoshibumi Matsushima
Affiliation:
Keywords: Polymorphisms, Wild Mice, nucleotide, Mus musuclus molossinus, genetic variation
Abstract: Personalized medicine offers a custom-made treatment for each patient directed by information of individuals genetic variation. Despite plenty of information about human single nucleotide polymorphisms (SNPs) and gene expression profile, predicting functions of genetic variations in humans is still a difficult task. Genetic analysis using experimental animals is possible to provide information about the functions of genetic polymorphisms over experimental invention in humans. In particular, inbred strains established from wild mice are valuable resources for analyzing functions of genetic polymorphisms. In this article, first I describe history of inbred strains derived from Japanese wild mice, Mus musuclus molossinus. Next, I discuss a mouse model for hyperlipidemia, which was isolated from a colony of Japanese wild mice. Interestingly, the hyperlipimic phenotypes are varied in congenic strains on other genetic backgrounds, reflecting phenotype variation of hyperlipidemia in human populations. Thus, further genetic analysis of Japanese wild mice can contribute to functional analysis of human genetic variation leading to personalized medicine.
Export Options
About this article
Cite this article as:
Matsushima Yoshibumi, The New Disease Models from Genetic Polymorphisms of Japanese Wild Mice, Current Pharmaceutical Biotechnology 2009; 10 (2) . https://dx.doi.org/10.2174/138920109787315097
DOI https://dx.doi.org/10.2174/138920109787315097 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews The Coronary Collateral Circulation in Man
Current Cardiology Reviews Pathophysiology of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Current Drug Therapy Fatty Liver and Ischemia/Reperfusion: Are there Drugs Able to Mitigate Injury?
Current Medicinal Chemistry A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents
Mini-Reviews in Medicinal Chemistry Current Concepts of Immunopathogenesis, Diagnosis and Therapy in Whipples Disease
Current Medicinal Chemistry Risk-Benefit Perspectives in COX-2 Blockade
Current Drug Safety Caffeic Acid Phenethyl Ester (CAPE), Active Phenolic Compound of Propolis Attenuates Endothelin, Prostaglandin F2α and U46619 Elicited Contractions of Isolated Human Umbilical Artery
Current Traditional Medicine In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia
Current Pharmaceutical Design The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardiovascular Complications in Patients with Turner’s Syndrome
Current Pharmaceutical Design Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design Therapeutic Strategies Targeting Endothelial Function in Humans:Clinical Implications
Current Vascular Pharmacology